# The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients

> **NCT05788341** · — · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05788341
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-30
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05788341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05788341, "The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05788341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*